Posted by Michael Wonder on 16 Dec 2021
PHARMAC looking to fund medicines for lung and ovarian cancer
16 December 2021 - PHARMAC is considering funding a bundle deal which would give New Zealanders more effective treatment options for lung cancer and ovarian cancer.
The bundle deal also includes a new medicine for people with severe eosinophilic asthma.
